JOURNAL ARTICLE

"Conservative Management of De Quervain's Stenosing Tenosynovitis: Review & Presentation of Treatment Algorithm"

Jad Abi-Rafeh, Roy Kazan, Tyler Safran, Stephanie Thibaudeau
Plastic and Reconstructive Surgery 2020 April 13
32301915

INTRODUCTION: Non-surgical management of De Quervain's disease relies mainly on the use of oral Non-Steroidal Anti-Inflammatory Drug administration, splint therapy, and corticosteroid injections. While the latter is most effective, with documented success rates of 61%-83%, there exists no clear consensus pertaining to conservative treatment protocols conferring the best outcomes. This article reports on all present conservative treatment modalities in use for the management of De Quervain's disease and highlights specific treatment- and patient-related factors associated with the best outcomes.

METHODS: A systematic search was performed using the PubMed database using appropriate search terms; two independent reviewers evaluated retrieved articles using strict inclusion and exclusion criteria.

RESULTS: A total of 66 articles met the inclusion criteria for review, comprising 22 articles reporting on outcomes following a single conservative treatment modality, 8 articles reporting on combined treatment approaches, 13 articles directly comparing different conservative treatment regimens, and 23 case reports.

CONCLUSIONS: A multimodal approach using splint therapy and corticosteroid injections appears to be more beneficial than either used in isolation. While there exists some evidence showing that multi-point injection techniques and multiple injections prior to surgical referral may provide benefit over a single point injection technique and a single injection prior to surgery, corticosteroid use is not benign and should thus be performed with caution. Ultrasound was proven valuable in the visualization of an intercompartmental septum, while ultrasound-guided injections were shown to be both more accurate and confer better outcomes. Several prior and concurrent medical conditions may affect conservative treatment outcome. A level I-II evidence-based treatment protocol is recommended for the optimal non-surgical management of De Quervain's disease.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
32301915
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"